Works matching DE "INTERFERON beta 1b"

Results: 326

Effectiveness of Unfocused vs. Focal Shock Waves Combined with Botulinum Toxin on Spasticity in Brain-Damaged Patients.

Published in:

Toxins, 2025, v. 17, n. 5, p. 209, doi. 10.3390/toxins17050209

By:

Déniz, Antonio;
Saavedra, Pedro;
Marrero, Isabel;
Barrera, Samuel;
Domínguez, Raúl;
Mendoza, Raúl;
Rodríguez, Jorge

Publication type:

Article

Letter to the Editor: Lazzaro responds to Rodríguez‑Sánchez et al.

Published in:

European Journal of Health Economics, 2023, v. 24, n. 4, p. 661, doi. 10.1007/s10198-022-01502-5

By:

Lazzaro, Carlo

Publication type:

Article

Prompt diagnosis can improve outcomes in multiple sclerosis.

Published in:

Practitioner, 2020, v. 264, n. 1841, p. 21

By:

Moccia, Marcello;
Thompson, Alan

Publication type:

Article

The application of HPLC/MS analysis with a multi-enzyme digest strategy to characterize different interferon product variants produced from Pichia pastoris.

Published in:

Amino Acids, 2019, v. 51, n. 9, p. 1353, doi. 10.1007/s00726-019-02772-9

By:

Wang, Yu;
Liu, Di;
Crowell, Laura E.;
Love, Kerry R.;
Wu, Shiaw-lin;
Hancock, William S.

Publication type:

Article

Development and Validation of a Bioanalytical Method for the Quantification of Nitrated Fatty Acids in Plasma Using LC-MS/MS: Application to Cardiovascular Patients.

Published in:

Separations (2297-8739), 2023, v. 10, n. 2, p. 87, doi. 10.3390/separations10020087

By:

Herz, Magy Maged;
Gad, Mohamed Zakaria;
Hanafi, Rasha Sayed

Publication type:

Article

Evaluation of serum levels of interferon beta (INF-B) and Nucleotide-binding oligomerization domain 2 (NOD2) gene polymorphism in children with atopic asthma phenotype.

Published in:

Alexandria Journal of Pediatrics, 2023, v. 36, n. 2, p. 113, doi. 10.4103/ajop.ajop_25_23

By:

Zedan, Magdy M. E.;
Aloraby, Rania S.;
Abousamra, Nashwa K.;
Wahba, Yahya;
Abd El-Hameed, Suzy A. El-Mabood

Publication type:

Article

Detection of legal highs in the urine of methadone‐treated patient by LC‐MS.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 3, p. 253, doi. 10.1111/bcpt.13270

By:

Labuz, Krzysztof;
Adamowicz, Piotr;
Kała, Maria;
Pyrc, Krzysztof;
Reszke, Edward;
Mielczarek, Przemyslaw;
Silberring, Jerzy;
Smoluch, Marek

Publication type:

Article

Molecular mechanism underlying the impact of vitamin D on disease activity of MS.

Published in:

Annals of Clinical & Translational Neurology, 2014, v. 1, n. 8, p. 605, doi. 10.1002/acn3.91

By:

Munger, Kassandra L.;
Köchert, Karl;
Simon, Kelly C.;
Kappos, Ludwig;
Polman, Chris H.;
Freedman, Mark S.;
Hartung, Hans P.;
Miller, David H.;
Montalbán, Xavier;
Edan, Gilles;
Barkhof, Frederik;
Pleimes, Dirk;
Sandbrink, Rupert;
Ascherio, Alberto;
Pohl, Christoph

Publication type:

Article

Interferon-β and temozolomide combination therapy for temozolomide monotherapy-refractory malignant gliomas.

Published in:

Molecular & Clinical Oncology, 2015, v. 3, n. 4, p. 169, doi. 10.3892/mco.2015.542

By:

HIROSHI KAWAJI;
TSUTOMU TOKUYAMA;
TOMOHIRO YAMASAKI;
SHINJI AMANO;
NAOTO SAKAI;
HIROKI NAMBA

Publication type:

Article

Vitamin D and Its Metabolites Status before and during Chemotherapy in Caucasian Breast Cancer Patients.

Published in:

Metabolites (2218-1989), 2023, v. 13, n. 9, p. 996, doi. 10.3390/metabo13090996

By:

Kimsa-Furdzik, Małgorzata;
Bednarek, Anna;
Hibner, Grzegorz;
Czajka-Francuz, Paulina;
Cisoń-Jurek, Sylwia;
Karawasiecka, Dobromiła;
Szymczak, Bożena;
Wojnar, Jerzy;
Chudek, Jerzy;
Francuz, Tomasz

Publication type:

Article

Mucopolysaccharidosis Type 1 among Children—Neuroradiological Perspective Based on Single Centre Experience and Literature Review.

Published in:

Metabolites (2218-1989), 2023, v. 13, n. 2, p. 209, doi. 10.3390/metabo13020209

By:

Machnikowska-Sokołowska, Magdalena;
Myszczuk, Aleksandra;
Wieszała, Emilia;
Wieja-Błach, Dominika;
Jamroz, Ewa;
Paprocka, Justyna

Publication type:

Article

A Marked Low-Grade Inflammation and a Significant Deterioration in Metabolic Status in First-Episode Schizophrenia: A Five-Year Follow-Up Study.

Published in:

Metabolites (2218-1989), 2022, v. 12, n. 10, p. 983, doi. 10.3390/metabo12100983

By:

Parksepp, Madis;
Haring, Liina;
Kilk, Kalle;
Taalberg, Egon;
Kangro, Raul;
Zilmer, Mihkel;
Vasar, Eero

Publication type:

Article

Metabolomics in Autoimmune Diseases: Focus on Rheumatoid Arthritis, Systemic Lupus Erythematous, and Multiple Sclerosis.

Published in:

Metabolites (2218-1989), 2021, v. 11, n. 12, p. 812, doi. 10.3390/metabo11120812

By:

Yoon, Naeun;
Jang, Ah-Kyung;
Seo, Yerim;
Jung, Byung Hwa

Publication type:

Article

Study of Fecal and Urinary Metabolite Perturbations Induced by Chronic Ethanol Treatment in Mice by UHPLC-MS/MS Targeted Profiling.

Published in:

Metabolites (2218-1989), 2019, v. 9, n. 10, p. 232, doi. 10.3390/metabo9100232

By:

Deda, Olga;
Virgiliou, Christina;
Orfanidis, Amvrosios;
Gika, Helen G.

Publication type:

Article

Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b–Literature Review and Personal Preliminary Experience.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.592543

By:

Mary, Aurélien;
Hénaut, Lucie;
Macq, Pierre Yves;
Badoux, Louise;
Cappe, Arnaud;
Porée, Thierry;
Eckes, Myriam;
Dupont, Hervé;
Brazier, Michel

Publication type:

Article

What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?

Published in:

Frontiers in Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fmicb.2022.843587

By:

Martinez, Miguel Angel

Publication type:

Article

Assessment of Medication Adherence Using a Medical App Among Patients With Multiple Sclerosis Treated With Interferon Beta-1b: Pilot Digital Observational Study (PROmyBETAapp).

Published in:

2019

By:

Limmroth, Volker;
Hechenbichler, Klaus;
Müller, Christian;
Schürks, Markus

Publication type:

journal article

The Impact of Interferon Beta-1b Therapy on Thyroid Function and Autoimmunity Among COVID-19 Survivors.

Published in:

Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.746602

By:

Lui, David Tak Wai;
Hung, Ivan Fan Ngai;
Lee, Chi Ho;
Lee, Alan Chun Hong;
Tam, Anthony Raymond;
Pang, Polly;
Ho, Tip Yin;
Cheung, Chloe Yu Yan;
Fong, Carol Ho Yi;
Law, Chun Yiu;
To, Kelvin Kai Wang;
Lam, Ching Wan;
Chow, Wing Sun;
Woo, Yu Cho;
Lam, Karen Siu Ling;
Tan, Kathryn Choon Beng

Publication type:

Article

Involvement of NINJ2 Protein in Inflammation and Blood–Brain Barrier Transmigration of Monocytes in Multiple Sclerosis.

Published in:

Genes, 2022, v. 13, n. 11, p. 1946, doi. 10.3390/genes13111946

By:

Sorosina, Melissa;
Peroni, Silvia;
Mascia, Elisabetta;
Santoro, Silvia;
Osiceanu, Ana Maria;
Ferrè, Laura;
Clarelli, Ferdinando;
Giordano, Antonino;
Cannizzaro, Miryam;
Martinelli Boneschi, Filippo;
Filippi, Massimo;
Esposito, Federica

Publication type:

Article

Anti-colorectal cancer effect of interleukin-2 and interferon-β fusion gene driven by carcinoembryonic antigen promoter.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 3259, doi. 10.2147/OTT.S97444

By:

Yan Wang;
Mengchun Wang;
Yan Li

Publication type:

Article

Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade.

Published in:

European Neurology, 2016, v. 75, n. 5/6, p. 274, doi. 10.1159/000446580

By:

Ribes García, Sara;
Gómez-Pajares, Fernando;
albelda Puig, Carmen;
García Herrera, José Luis;
Casanova Estruch, Bonaventura

Publication type:

Article

From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study.

Published in:

European Neurology, 2014, v. 71, n. 5/6, p. 233, doi. 10.1159/000356786

By:

Prosperini, Luca;
Mancinelli, Chiara Rosa;
Pozzilli, Carlo;
Grasso, Maria Grazia;
Clemenzi, alessandro;
Collorone, Sara;
Pontecorvo, Simona;
Francia, ada;
Villani, Veronica;
Koudriavtseva, Tatiana;
Buttari, Fabio;
Centonze, Diego;
Di Battista, Giancarlo;
Frisullo, Giovanni;
Galgani, Simonetta;
Gasperini, Claudio

Publication type:

Article

Multiple sclerosis 2.

Published in:: European Journal of Neurology, 2002, v. 9, p. 218, doi. 10.1111/j.1468-1331.2002.tb00053.x
Publication type:: Article

MS TREATMENT OPTIMIZATION: FACTORS ASSOCIATED WITH POOR CLINICAL RESPONSE IN NAB POSITIVE PATIENTS.

Published in:

Romanian Journal of Neurology, 2016, v. 15, n. 3, p. 119, doi. 10.37897/rjn.2016.3.3

By:

Cornea, A.;
Tudor, R.;
Petre, A.;
Simu, M.

Publication type:

Article

MS TREATMENT OPTIMIZATION: FACTORS ASSOCIATED WITH POOR CLINICAL RESPONSE IN NAB POSITIVE PATIENTS.

Published in:

Romanian Journal of Medical Practice, 2016, v. 11, n. 3, p. 119

By:

Cornea, A.;
Tudor, R.;
Petre, A.;
Simu, M.

Publication type:

Article

Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.

Published in:

2021

By:

Aricò, Eleonora;
Castiello, Luciano;
Bracci, Laura;
Urbani, Francesca;
Lombardo, Flavia;
Bacigalupo, Ilaria;
Ancidoni, Antonio;
Vanacore, Nicola;
Falcione, Alessandro;
Reggiani, Chiara;
Dutti, Giovanni Marco;
Maglie, Maria Grazia;
Papa, Ombretta;
Bartoletti, Pier Luigi;
Ozzella, Giuseppina;
Bevilacqua, Nazario;
Nicastri, Emanuele;
Belardelli, Filippo;
Sconocchia, Giuseppe

Publication type:

Letter

Reversible oxidation/reduction steps in the metabolic degradation of the glycerol side chain of the S1P<sub>1</sub> modulator ponesimod.

Published in:

Xenobiotica, 2024, v. 54, n. 4, p. 182, doi. 10.1080/00498254.2024.2319812

By:

Treiber, Alexander;
Seeland, Swen;
Segrestaa, Jérôme;
Lescop, Cyrille;
Bolli, Martin H.

Publication type:

Article

Preclinical pharmacokinetic investigation of the bioavailability and skin distribution of HY-072808 ointment, a novel drug candidate for the treatment of atopic dermatitis, in minipigs by a newly LC-MS/MS method.

Published in:

Xenobiotica, 2024, v. 54, n. 3, p. 138, doi. 10.1080/00498254.2024.2333007

By:

Shao, Li;
Mo, Jiajia;
Xu, Qinlong;
He, Guangwei;
Xing, Chunyu;
Chu, Zhaoxing

Publication type:

Article

Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.

Published in:

PLoS Pathogens, 2016, v. 12, n. 1, p. 1, doi. 10.1371/journal.ppat.1005378

By:

Stifter, Sebastian A.;
Bhattacharyya, Nayan;
Pillay, Roman;
Flórido, Manuela;
Triccas, James A.;
Britton, Warwick J.;
Feng, Carl G.

Publication type:

Article

EU legal and regulatory update May 2024.

Published in:: Journal of Generic Medicines, 2024, v. 20, n. 2, p. 90, doi. 10.1177/17411343241260142
Publication type:: Article

Comparative treatment effectiveness of oral fingolimod and conventional injectable disease‐modifying agents in multiple sclerosis.

Published in:

Pharmacotherapy, 2021, v. 41, n. 5, p. 440, doi. 10.1002/phar.2517

By:

Earla, Jagadeswara R.;
Hutton, George J.;
Thornton, Douglas J.;
Chen, Hua;
Johnson, Michael L.;
Aparasu, Rajender R.

Publication type:

Article

Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple Sclerosis.

Published in:

Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 565, doi. 10.1007/s40801-023-00387-x

By:

Geiger, Caroline Kelley;
Sheinson, Daniel;
To, Tu My;
Jones, David;
Bonine, Nicole Gidaya

Publication type:

Article

Real-World Assessment of Interferon-β-1b and Interferon-β-1a Adherence Before and After the Introduction of the BETACONNECT<sup>®</sup> Autoinjector: A Retrospective Cohort Study.

Published in:

Drugs - Real World Outcomes, 2021, v. 8, n. 3, p. 359, doi. 10.1007/s40801-021-00248-5

By:

Butler, Oisín;
Heeg, Simone;
Holl, Katsiaryna;
Frenz, Ann-Kathrin;
Wicklein, Eva-Maria;
Rametta, Mark;
Yeo, Sandy

Publication type:

Article

Activation of Type I Interferon Signal Pathway in Patients with Multiple Sclerosis by the Russian Analog of β-Interferon-1b (transcriptional profiling data).

Published in:

Neuroscience & Behavioral Physiology, 2015, v. 45, n. 8, p. 847, doi. 10.1007/s11055-015-0154-0

By:

Danilova, L.;
Popova, E.;
Kulakova, O.;
Tsareva, E.;
Favorov, A.;
Favorova, O.;
Boiko, A.

Publication type:

Article

Genotypes Variation of Interferon-gamma gene with chronic hypertension risk.

Published in:

Revista Latinoamericana de Hipertension, 2022, v. 17, n. 5, p. 338, doi. 10.5281/zenodo.7369239

By:

Dhabaan, Anwar Abed Nasser

Publication type:

Article

Xenopus Interferon Complex: Inscribing the Amphibiotic Adaption and Species-Specific Pathogenic Pressure in Vertebrate Evolution?

Published in:

Cells (2073-4409), 2020, v. 9, n. 1, p. 1, doi. 10.3390/cells9010067

By:

Yun Tian;
Jennings, Jordan;
Yuanying Gong;
Yongming Sang

Publication type:

Article

Novel potential pharmacological applications of dimethyl fumarate--an overview and update.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1264842

By:

Bresciani, Giorgia;
Manai, Federico;
Davinelli, Sergio;
Tucci, Paolo;
Saso, Luciano;
Amadio, Marialaura

Publication type:

Article

Mechanisms of interferon-beta-induced inhibition of T oxoplasma gondii growth in murine macrophages and embryonic fibroblasts: role of immunity-related GTPase M1.

Published in:

Cellular Microbiology, 2015, v. 17, n. 7, p. 1069, doi. 10.1111/cmi.12423

By:

Mahmoud, Motamed Elsayed;
Ui, Fumiki;
Salman, Doaa;
Nishimura, Maki;
Nishikawa, Yoshifumi

Publication type:

Article

Editorial: HBsAg seroclearance after pegylated interferon treatment—The beginning of the end. Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 10, p. 1105, doi. 10.1111/apt.17710

By:

Gao, Na;
Guan, Guiwen;
Zhao, Qiyi;
Gao, Zhiliang

Publication type:

Article

Editorial: HBsAg seroclearance after pegylated interferon treatment—The beginning of the end.

Published in:

2023

By:

Mak, Lung‐Yi

Publication type:

Editorial

A closer look at reported colitis in association with multiple sclerosis treatments.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 3, p. 453, doi. 10.1177/13524585231205964

By:

Porwal, Mokshal H;
Obeidat, Ahmed Z

Publication type:

Article

Advancing assessment of cognitive change in multiple sclerosis: Seeking valid and sensitive approaches beyond simple cut-offs.

Published in:

Multiple Sclerosis Journal, 2024, v. 30, n. 2, p. 276, doi. 10.1177/13524585231221409

By:

Motyl, Jiri

Publication type:

Article

Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex).

Published in:

2021

By:

Cohan, Stanley L.;
Hendin, Barry A.;
Reder, Anthony T.;
Smoot, Kyle;
Avila, Robin;
Mendoza, Jason P.;
Weinstock-Guttman, Bianca

Publication type:

journal article

Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study.

Published in:

CNS Drugs, 2020, v. 34, n. 12, p. 1275, doi. 10.1007/s40263-020-00775-9

By:

Pilo de la Fuente, Belen;
Sabín, Julia;
Galán, Victoria;
Thuissard, Israel;
Sainz de la Maza, Susana;
Costa-Frossard, Lucienne;
Gómez-Moreno, Mayra;
Díaz-Díaz, Judit;
Oreja-Guevara, Celia;
Lozano-Ros, Alberto;
García-Domínguez, José M.;
Borrego, Laura;
Ayuso, Lucía;
Castro, Andy;
Sánchez, Pedro;
Meca-Lallana, Virginia;
Muñoz, Carmen;
Casanova, Ignacio;
López de Silanes, Carlos;
Martín, Hugo

Publication type:

Article

Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study.

Published in:

2020

By:

Naismith, Robert T.;
Wundes, Annette;
Ziemssen, Tjalf;
Jasinska, Elzbieta;
Freedman, Mark S.;
Lembo, Anthony J.;
Selmaj, Krzysztof;
Bidollari, Ilda;
Chen, Hailu;
Hanna, Jerome;
Leigh-Pemberton, Richard;
Lopez-Bresnahan, Maria;
Lyons, Jennifer;
Miller, Catherine;
Rezendes, David;
Wolinsky, Jerry S.;
EVOLVE-MS-2 Study Group

Publication type:

journal article

Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis.

Published in:

2019

By:

Nicoletti, Carolina Gabri;
Landi, Doriana;
Monteleone, Fabrizia;
Mataluni, Giorgia;
Albanese, Maria;
Lauretti, Benedetta;
Rocchi, Camilla;
Simonelli, Ilaria;
Boffa, Laura;
Buttari, Fabio;
Mercuri, Nicola Biagio;
Centonze, Diego;
Marfia, Girolama Alessandra

Publication type:

journal article

Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.

Published in:

Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00695

By:

Romano, Silvia;
Ferraldeschi, Michela;
Bagnato, Francesca;
Mechelli, Rosella;
Morena, Emanuele;
Caldano, Marzia;
Buscarinu, Maria Chiara;
Fornasiero, Arianna;
Frontoni, Marco;
Nociti, Viviana;
Mirabella, Massimiliano;
Mayer, Flavia;
Bertolotto, Antonio;
Pozzilli, Carlo;
Vanacore, Nicola;
Salvetti, Marco;
Ristori, Giovanni

Publication type:

Article

Immune response genes receptors expression and polymorphisms in relation to multiple sclerosis susceptibility and response to INF- β therapy.

Published in:

IUBMB Life, 2016, v. 68, n. 9, p. 727, doi. 10.1002/iub.1530

By:

Karam, Rehab A.;
Rezk, Noha A.;
Amer, Mona M.;
Fathy, Hala A.

Publication type:

Article

Real-World Use of Intradetrusor Botulinum Toxin Injections: A Population-Based Study from France.

Published in:

Toxins, 2024, v. 16, n. 10, p. 423, doi. 10.3390/toxins16100423

By:

Ruffion, Alain;
Karam, Pierre;
Forestier, Anne;
Denys, Pierre

Publication type:

Article

Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study.

Published in:

Toxins, 2023, v. 15, n. 4, p. 280, doi. 10.3390/toxins15040280

By:

Bensmail, Djamel;
Karam, Pierre;
Forestier, Anne;
Loze, Jean-Yves;
Lévy, Jonathan

Publication type:

Article